English Deutsch 中文
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
Menu Deutsch 中文

China's BravoVax In-Licenses Rotavirus Vaccine for Infants

Oct. 11, 2014

On October 11, 2014, BravoVax Co., Ltd., a Chinese company, and the International Medica Foundation announced  the closing of a licensing agreement for BravoVax' rotavirus vaccine (RRV-TV) candidate, which has been successfully tested in a large Phase 2 clinical trial to protect neonates from diarrhea caused by rotavirus.